Materiały źródłowe

• #1 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical lobular and ductal hyperplasias are considered high-risk, pre-cursor, or pre-malignant lesions associated with either progression to advanced neoplasms or a marker for developing metachronous or synchronous breast cancer. […] A genomic change from the damaging effects of carcinogens is one of the leading theories behind the development of atypical proliferative lesions and breast cancer. […] One of the leading players in initiating this genomic change is estrogen. […] This life-long exposure to estrogen possibly represents a continued accumulation of genomic changes and damage, which may lead to the development of atypical proliferative breast lesions. […] When ADH or ALH is identified in a breast biopsy, the risk of developing DCIS or invasive breast cancer increases by four to five times with a 2:1 predilection for the ipsilateral breast versus contralateral.

• #2 Atypical hyperplasia of the breast | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] It’s not clear what causes atypical hyperplasia of the breast. […] Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer.

• #3 Atypical hyperplasia of the breast // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/atypical-hyperplasia-of-the-breast

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] It’s not clear what causes atypical hyperplasia of the breast. Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. […] Both types of atypical hyperplasia increase the risk of breast cancer. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time.

• #4 Atypical hyperplasia of the breast // Middlesex Health

  https://middlesexhealth.org/learning-center/diseases-and-conditions/atypical-hyperplasia-of-the-breast

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. […] Atypical hyperplasia of the breast isn’t breast cancer. But it’s a sign that you have an increased risk of breast cancer in the future. […] It’s not clear what causes atypical hyperplasia of the breast. Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. […] Both types of atypical hyperplasia increase the risk of breast cancer. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time.

• #5 Atypical hyperplasia of the breast | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] It’s not clear what causes atypical hyperplasia of the breast. […] Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer.

• #6 Atypical hyperplasia of the breast | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/atypical-hyperplasia-breast

  Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar.

• #7 Atypical hyperplasia of the breast | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20369759/

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Its not clear what causes atypical hyperplasia of the breast. Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cells DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer.

• #8 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  It is unclear if a precursor lesion exists for high-grade DCIS or invasive carcinoma; however, breast cancer relative risk is increased four times when atypical hyperplasia is identified on a breast biopsy. […] Molecular studies have identified important agents related to un-checked proliferation, including cyclin D1 overexpression, p16 inactivation, HOXA inactivation, and activation of telomerase. […] The sequence and interplay of these changes are not well understood, but further studies in their relation to each other and the development of atypical proliferative lesions and breast cancer could shed light on accurate risk stratification, prognosis, and early predictors of advanced neoplasia.

• #9 Atypical Breast Hyperplasia – MD Searchlight

  https://mdsearchlight.com/womens-health/atypical-breast-hyperplasia/

  At the molecular level, researchers have identified key elements related to uncontrolled cell growth, which include overproduction of cyclin D1, inactivation of p16 and HOXA, and activation of telomerase. These changes can inhibit cell death and promote the development of cancer. The exact order and interconnection of these events are still not completely understood. However, its hoped that future research will help us understand more about these abnormal growths, leading to more accurate risk assessment, prognosis, and early identification of advanced tumors. […] Atypical Breast Hyperplasia can be caused by exposure to damaging substances related to cancer, such as estrogen.

• #10 Pathology Outlines – Atypical ductal hyperplasia

  https://www.pathologyoutlines.com/topic/breastadh.html

  EZH2 (enhancer of zeste homolog 2) overexpression has an important role in oncogenesis (Arch Pathol Lab Med 2018;142:1182) […] Lifelong exposure to estrogen causes a continued accumulation of genomic changes that leads to defective growth control (Cancer Prev Res (Phila) 2014;7:211) […] Shared alterations with low grade ductal carcinoma in situ: gains 1q and loss 16q-17p (Histopathology 2010;57:171)

• #11 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical lobular and ductal hyperplasias are considered high-risk, pre-cursor, or pre-malignant lesions associated with either progression to advanced neoplasms or a marker for developing metachronous or synchronous breast cancer. […] A genomic change from the damaging effects of carcinogens is one of the leading theories behind the development of atypical proliferative lesions and breast cancer. […] One of the leading players in initiating this genomic change is estrogen. […] This life-long exposure to estrogen possibly represents a continued accumulation of genomic changes and damage, which may lead to the development of atypical proliferative breast lesions. […] When ADH or ALH is identified in a breast biopsy, the risk of developing DCIS or invasive breast cancer increases by four to five times with a 2:1 predilection for the ipsilateral breast versus contralateral.

• #12 Case: Atypical Ductal Hyperplasia – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/atypical-ductal-hyperplasia

  Atypical ductal hyperplasia (ADH) is a non-malignant but high-risk lesion associated with progression to more advanced neoplasms including ductal carcinoma in situ (DCIS) and invasive carcinoma, and as a marker for the development of additional breast cancer. […] Estrogen exposure is the primary risk factor for the development of atypical ductal hyperplasia. Estrogen and its metabolites have associated DNA-damaging effects, which lead to abnormal growth control and unchecked proliferation within breast tissue. […] However, accumulated genomic changes throughout a patients lifetime via exposure to estrogen are likely the major player behind the development of ADH and other pre-malignant and malignant lesions. […] Additional risk factors for ADH are similar to those for invasive carcinoma, including a family history of breast cancer and BRCA1/BRCA2 mutations.

• #13 Pathology Outlines – Atypical ductal hyperplasia

  https://www.pathologyoutlines.com/topic/breastadh.html

  EZH2 (enhancer of zeste homolog 2) overexpression has an important role in oncogenesis (Arch Pathol Lab Med 2018;142:1182) […] Lifelong exposure to estrogen causes a continued accumulation of genomic changes that leads to defective growth control (Cancer Prev Res (Phila) 2014;7:211) […] Shared alterations with low grade ductal carcinoma in situ: gains 1q and loss 16q-17p (Histopathology 2010;57:171)

• #14 Atypical Breast Hyperplasia – MD Searchlight

  https://mdsearchlight.com/womens-health/atypical-breast-hyperplasia/

  Atypical lobular and ductal hyperplasias are abnormal growths in the breast that are considered to be high risk. It is believed that they could either progress to advanced tumors, or be a warning sign of future breast cancer. Studies suggest that these growths can be a result of changes in the genes of normal breast tissue, that lead to uncontrolled growth. One of the main causes of these genetic changes is thought to be exposure to damaging substances related to cancer. […] One such damaging substance could be estrogen, a hormone that women are exposed to in varying amounts throughout their lives. Estrogen and its byproducts have been linked with causing damage to the DNA, leading to abnormal growth, mainly in luminal progenitor cells the cells lining the breast ducts and lobules. Over a lifetime, its believed that continuous exposure to estrogen can result in a build-up of these genetic changes, which could potentially result in atypical growths in the breast.

• #15 Case: Atypical Ductal Hyperplasia – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/atypical-ductal-hyperplasia

  Atypical ductal hyperplasia (ADH) is a non-malignant but high-risk lesion associated with progression to more advanced neoplasms including ductal carcinoma in situ (DCIS) and invasive carcinoma, and as a marker for the development of additional breast cancer. […] Estrogen exposure is the primary risk factor for the development of atypical ductal hyperplasia. Estrogen and its metabolites have associated DNA-damaging effects, which lead to abnormal growth control and unchecked proliferation within breast tissue. […] However, accumulated genomic changes throughout a patients lifetime via exposure to estrogen are likely the major player behind the development of ADH and other pre-malignant and malignant lesions. […] Additional risk factors for ADH are similar to those for invasive carcinoma, including a family history of breast cancer and BRCA1/BRCA2 mutations.

• #16 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Atypical hyperplasia is found in approximately 10% of all benign breast biopsies. […] Once a woman is diagnosed with atypical hyperplasia, she has a cumulative incidence of breast cancer (either ductal carcinoma in situ or invasive cancer) of 30% over the next 25 years, based on the Mayo Clinic Cohort study. […] The risk of breast cancer is higher in those diagnosed with atypical hyperplasia at a younger age and in those with a greater number of foci containing atypia. […] 97% of atypical ductal hyperplasia and 88% of atypical lobular hyperplasia has estrogen receptor staining, meaning it is stimulated by estrogen. […] Because of this, medications called selective estrogen receptor modulators (for example, tamoxifen and raloxifene) and aromatase inhibitors (for example, exemestane, anastrozole, and letrozole) have been shown in clinical trials to effectively reduce the risk of breast cancer associated with these lesions.

• #17 Atypical Ductal Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562244/

  Atypical ductal hyperplasia (ADH) is a pathology finding, usually found incidentally on biopsy of the breast. […] The etiology of atypical ductal hyperplasia is unknown; however, ADH is more prevalent in patients with a strong family history of breast cancer. […] Hoogerbrugge et al. found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study. […] Additionally, a study from 2009 demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.

• #18 Atypical Ductal Hyperplasia – MD Searchlight

  https://mdsearchlight.com/womens-health/atypical-ductal-hyperplasia/

  A 2009 study also showed that the occurrences of ADH dropped as the usage of hormone therapies after menopause decreased. This alludes to the possibility that these therapies might have been a factor in causing ADH. […] The exact cause of Atypical Ductal Hyperplasia (ADH) is not clearly understood, but it may occur more frequently in patients with a strong family history of breast cancer. Hormone therapies after menopause have also been suggested as a possible factor.

• #19 Atypical hyperplasia of the breast | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/atypical-hyperplasia-breast

  There are no specific risk factors for atypical hyperplasia of the breast. Atypical hyperplasia is one of several conditions that cause a growth of cells in the breast that isn’t cancerous. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer.

• #20 Atypical hyperplasia of the breast – Hancock Health

  https://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. […] Its not clear what causes atypical hyperplasia of the breast. Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. […] There are no specific risk factors for atypical hyperplasia of the breast. Atypical hyperplasia is one of several conditions that cause a growth of cells in the breast that isnt cancerous. […] If youve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who dont have atypical hyperplasia. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. […] Its not clear whether theres anything that can prevent atypical hyperplasia of the breast. […] Atypical hyperplasia of the breast increases the risk of breast cancer.

• #21 Atypical Ductal Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562244/

  Atypical ductal hyperplasia (ADH) is a pathology finding, usually found incidentally on biopsy of the breast. […] The etiology of atypical ductal hyperplasia is unknown; however, ADH is more prevalent in patients with a strong family history of breast cancer. […] Hoogerbrugge et al. found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study. […] Additionally, a study from 2009 demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.

• #22 Atypical Ductal Hyperplasia – MD Searchlight

  https://mdsearchlight.com/womens-health/atypical-ductal-hyperplasia/

  Atypical ductal hyperplasia (ADH) is a condition detected in breast tissue. Its often found by accident during a needle biopsy, which is a procedure often carried out after unusual results on a mammogram. ADH is associated with a higher risk of breast cancer, leading it to be labeled a high risk condition. However, its not seen as a direct forerunner to cancer, because the breast cancer linked to ADH could pop up anywhere in the breasts, not just where ADH is spotted. […] While the exact cause of atypical ductal hyperplasia (ADH), a breast condition, is not clearly understood, it seems to occur more frequently in patients who have a strong family history of breast cancer. This was evidenced in a study which revealed that about half the women who chose to have their breasts surgically removed to prevent breast cancer (due to a high family risk) had high-risk breast conditions, and 39% of these were ADH. This suggests that the condition might have a genetic connection, although further research is still needed to confirm this hypothesis.

• #23 Atypical Ductal Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562244/

  Atypical ductal hyperplasia (ADH) is a pathology finding, usually found incidentally on biopsy of the breast. […] The etiology of atypical ductal hyperplasia is unknown; however, ADH is more prevalent in patients with a strong family history of breast cancer. […] Hoogerbrugge et al. found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study. […] Additionally, a study from 2009 demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.

• #24 Atypical Ductal Hyperplasia | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/45

  The etiology of atypical ductal hyperplasia is unknown; however, ADH is more prevalent in patients with a strong family history of breast cancer. […] Hoogerbrugge et al. found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study. […] Additionally, a study from 2009 demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.

• #25 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  Atypical ductal hyperplasia (ADH) is a common diagnosis in the mammographic era and a significant clinical problem with wide variation in diagnosis and treatment. […] While ADH is considered a non-obligate precursor of invasive carcinoma, the molecular taxonomy remains unknown. […] ADH is not only a risk factor for IDC, it is also considered to be a direct but non-obligate precursor to carcinoma. […] However, Hartmann et al. pointed out that risk estimation has not been calculated as cumulative incidence by the current breast cancer risk prediction tools, and that the lifetime incidence is 25-30% according to multiple large retrospective studies. […] Strikingly, the risk associated with ADH is doubled with family history, suggesting inherited factors are associated with ADH development.

• #26 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  A specific cause for atypical ductal hyperplasia is unknown. Normal cells overproduce. And as that continues, they begin to become irregular. If the condition is not properly managed, it will continue to progress and eventually become breast cancer. It may also affect nearby tissues. […] The risk factors for ADH are similar to those for all types of breast cancer, including: […] Getting older: The risk for breast cancer and benign breast conditions increases with age; most breast cancers are diagnosed after age 50. […] Genetic mutations: Inherited mutation of certain genes, such as BRCA1 and BRCA2 […] Reproductive health history: This includes early menstruation (before age 12) and starting menopause after age 55. Having a pregnancy after age 30, not breastfeeding, and never having a full-term pregnancy are also risk factors.

• #27 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  A specific cause for atypical ductal hyperplasia is unknown. Normal cells overproduce. And as that continues, they begin to become irregular. If the condition is not properly managed, it will continue to progress and eventually become breast cancer. It may also affect nearby tissues. […] The risk factors for ADH are similar to those for all types of breast cancer, including: […] Getting older: The risk for breast cancer and benign breast conditions increases with age; most breast cancers are diagnosed after age 50. […] Genetic mutations: Inherited mutation of certain genes, such as BRCA1 and BRCA2 […] Reproductive health history: This includes early menstruation (before age 12) and starting menopause after age 55. Having a pregnancy after age 30, not breastfeeding, and never having a full-term pregnancy are also risk factors.

• #28 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #29 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  The occurrence of ADH in the general population varies widely from 3% of benign biopsies to 8-10%, to 23%. […] These differences may also reflect geographical or temporal differences in incidence, as ADH is associated with hormone replacement therapy (HRT), use of which varies widely over time. […] Given the high upgrade rate, it is not surprising that the majority of clinicians suggest a surgical excision after ADH diagnosis on CNB to rule out concomitant malignancy. […] Unfortunately, risk prediction following ADH diagnosis is controversial, and counseling and further screening for these women diagnosed with ADH are therefore probably not adequate. […] Thus far, despite the high risk of developing cancer associated with ADH, attempts to identify clinicopathological or molecular biomarkers to predict individual risk have been unsuccessful. […] Overall, the various limitations of all the previous studies discussed in this review need to be overcome in any future study of ADH.

• #30 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #31 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #32 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #33 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #34 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #35 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Have dense breast tissue: Dense breasts have more connective tissue than fatty tissue, which allows cancerous cells room to grow. […] Family history: A woman’s risk is higher if she has a first-degree relative (parent, sibling, child) who has had breast cancer, or multiple family members (on both parents’ sides) who have had breast cancer. […] Previous radiation treatments: A woman who has had previous radiation therapy to her chest or breasts before age 30 has a higher risk of getting breast cancer. […] Activity level and/or weight: Not being active and/or being overweight after menopause can increase your risk. […] Taking hormones: Birth control pills and hormone replacement therapy have been shown to raise risk. […] Alcohol consumption: Overconsumption of alcohol may play a role. […] Carcinogen exposure: Exposure to substances that cause cancer, including smoking, also increases the risk for breast cancer and benign breast conditions.

• #36 Understanding Atypical Ductal Hyperplasia: Its Causes, Diagnosis, and Treatment – BeatCancer

  https://beatcancer.eu/atypical-ductal-hyperplasia-adh/

  Atypical ductal hyperplasia (ADH) is a non-malignant condition where breast duct cells are multiplying abnormally, creating a higher risk for breast cancer. […] The exact cause of ADH is yet to be known. However, genetic factors and a history of similar conditions in the family could increase the risk of developing ADH. […] Besides genetics, environmental factors and lifestyle choices might also play a role. Factors like late childbearing, hormonal influences, obesity, or having a diet high in saturated fat could contribute to ADH. […] ADH is strongly associated with an increased risk of breast cancer, making it a condition that needs serious attention.

• #37 Atypical Hyperplasia of Breast | Symptoms, Causes & Treatment

  https://fitwellhub.pk/atypical-hyperplasia/

  Atypical hyperplasia is a benign condition in the breast in which abnormal cells are present within the breast tissue. The causes of atypical hyperplasia are not known, but the following factors may contribute to abnormal cell formation in the breast tissues: […] Dysregulation of hormonal levels, particularly of the estrogen hormone, may cause atypical hyperplasia by stimulating abnormal cell growth due to hormonal changes in the breast tissue. […] Some genetic mutations, for example, the BRCA1 or BRCA2 gene mutations, lead to an increased risk of abnormal breast cell development and atypical hyperplasia. […] If there is cancer or atypical hyperplasia in your family history, the possibility of developing the disease is higher. The relatedness may be partially due to genetics. […] Radiation exposure and other environmental factors, including some chemicals, can contribute to atypical cell growth in the breasts. […] Atypical hyperplasia can occur in most women after age 40 because the cell growth patterns may change, increasing the risk of abnormal cell development.

• #38 Atypical hyperlasia of the breast | The London Clinic

  https://www.thelondonclinic.co.uk/services/conditions/atypical-hyperplasia-breast

  Atypical hyperplasia of the breast is a condition in which breast tissue enlarges and overgrows. […] It is not known exactly what causes atypical hyperplasia. It can sometimes arise in women with ductal papilloma. […] It is important to remember that, while atypical hyperplasia is linked with a slightly increased risk of developing breast cancer in the future, this does not mean that it will happen to everyone with atypical hyperplasia. […] In some cases, where the risk of developing breast cancer is thought to be particularly high, possibly due to the presence of other risk factors such as family history, you may need further risk reduction treatment.

• #39 Ductal papilloma with atypical ductal hyperplasia – Understanding the importance of immunohistochemistry- A case report – JDPO

  https://www.jdpo.org/html-article/15961

  Solitary intraductal papilloma of the breast is a common benign mammary proliferative disease and is the most common neoplasm associated with nipple discharge in women. […] The presence of ADH within a papilloma and/or in the surrounding breast is associated with an increased risk of recurrence or invasive carcinoma. […] The present study undertakes to fully describe the morphological changes occurring within the epithelial component of central papillomas and to search for factors of prognostic significance concerning recurrence, progression and differentiation of atypical ductal hyperplasia. […] An intraductal papilloma can be subject to a spectrum of morphological changes ranging from metaplasia to usual ductal hyperplasia(UDH), atypical hyperplasia (ADH) or could co exists with similar lesions in adjoining in the breast across the broad spectrum of benign, high risk and malignant lesions.

• #40 Atypical Changes in the Breast Tissue Dublin, IE | Breast Inflammation Dublin | Breast Infection Ireland

  https://www.breastsurgeryireland.com/atypical-changes-in-breast-tissue-general-reconstructive-aesthetic-breast-surgery-dublin.html

  An accumulation of abnormal cells in the breast is referred to as atypical changes in the breast tissue. […] Factors that can turn normal cells into atypical cells include: Normal ageing, Inflammation and infection. […] Although atypical cells are non-cancerous, they can enhance a patients chances of developing cancer in their lifetime. […] The above conditions increase a patients chance of developing breast cancer four-fold. […] Other complications of abnormal atypical changes in breast tissue include lobular neoplasia and lobular carcinoma in-situ. These increase the patients chances of developing breast cancer ten-fold. […] Usually, atypical cells are non-cancerous. However, they can enhance a patients chances of developing cancer in their lifetime.

• #41 Atypical hyperplasia of the breast | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/atypical-hyperplasia-of-the-breast?content_id=CON-20369759

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] It’s not clear what causes atypical hyperplasia of the breast. […] Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer.

• #42 Atypical hyperplasia of the breast | UM Health-Sparrow

  https://www.uofmhealthsparrow.org/departments-conditions/conditions/atypical-hyperplasia-breast

  Atypical hyperplasia of the breast happens when cells in the breast tissue develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. The changes tell the cell to make many more cells. This causes a buildup of cells in the breast. Healthcare professionals call this buildup hyperplasia. The changes also turn the cells into atypical cells. This means that the cells look different from typical cells. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. More research is needed to understand how this happens. […] Both types of atypical hyperplasia increase the risk of breast cancer. Treatment for both types is similar.

• #43 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical lobular and ductal hyperplasias are considered high-risk, pre-cursor, or pre-malignant lesions associated with either progression to advanced neoplasms or a marker for developing metachronous or synchronous breast cancer. […] A genomic change from the damaging effects of carcinogens is one of the leading theories behind the development of atypical proliferative lesions and breast cancer. […] One of the leading players in initiating this genomic change is estrogen. […] This life-long exposure to estrogen possibly represents a continued accumulation of genomic changes and damage, which may lead to the development of atypical proliferative breast lesions. […] When ADH or ALH is identified in a breast biopsy, the risk of developing DCIS or invasive breast cancer increases by four to five times with a 2:1 predilection for the ipsilateral breast versus contralateral.

• #44 Breast Hyperplasia (Ductal or Lobular) | Benign Conditions | American Cancer Society

  https://www.cancer.org/cancer/types/breast-cancer/non-cancerous-breast-conditions/hyperplasia-of-the-breast-ductal-or-lobular.html

  Hyperplasia can affect your risk for breast cancer, but how much depends on what type it is: […] Atypical hyperplasia (either ADH or ALH): The risk of breast cancer is about 4 to 5 times higher than that of a woman with no breast abnormalities. […] Both ADH and ALH are linked to a higher risk of breast cancer. Even though most women with ADH or ALH will not develop breast cancer, it’s still important to talk with a health care provider about your risk and what you can do about it.

• #45 Benign Breast Disease (BBD) | Susan G. Komen®

  https://www.komen.org/breast-cancer/facts-statistics/benign-breast-conditions/

  Benign breast conditions are not breast cancer. However, proliferative breast conditions (those that have quickly growing cells) and those with abnormal-looking cells are linked to an increased risk of breast cancer. […] For example, women who have atypical hyperplasia have an increased risk of breast cancer. […] Women with atypical hyperplasia have about 3 to 5 times the breast cancer risk of women without a proliferative breast condition. […] The NCCN strongly recommends women with atypical hyperplasia (but not usual hyperplasia) take a risk-reducing drug (such as tamoxifen) to lower their risk of breast cancer. […] Taking a risk-reducing drug can lower the risk of breast cancer in women with atypical hyperplasia by about 86%.

• #46 Atypical hyperplasia of the breast | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/breast/what-is-breast-cancer/non-cancerous-conditions/atypical-hyperplasia

  Hyperplasia is an increase in the number of normal cells growing in a tissue. Atypical hyperplasia means that the cells that are increasing in a tissue are abnormal. […] Having atypical hyperplasia increases the risk for breast cancer. This risk is even higher in women who have a family history of breast cancer or who are diagnosed with atypical hyperplasia before they reach menopause. Breast cancer is more likely to start in the breast where atypical hyperplasia is found. The risk of developing breast cancer is greatest 10-15 years after atypical hyperplasia is diagnosed. The risk begins to go down after 15 years. […] Women with atypical hyperplasia should talk to their healthcare team about the benefits and possible risks of taking SERMs to reduce their risk of breast cancer.

• #47 Breast Pre-Cancer Conditions | Atypical Hyperplasia Treatment

  https://www.drnicoleyap.com.au/breast-pre-cancer-conditions/

  It is not clear what causes atypical hyperplasia. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. […] Once diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who do not have hyperplasia. […] The breast cancer risk with women with atypical hyperplasia increases over time: At 5 years after diagnosis, about 7% of women with atypical hyperplasia may develop breast cancer. […] At 10 years after diagnosis, about 13% of women with atypical hyperplasia may develop breast cancer. […] At 25 years after diagnosis, about 30% of women with atypical hyperplasia may develop breast cancer.

• #48 Atypical hyperplasia of the breast | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/breast/what-is-breast-cancer/non-cancerous-conditions/atypical-hyperplasia

  Hyperplasia is an increase in the number of normal cells growing in a tissue. Atypical hyperplasia means that the cells that are increasing in a tissue are abnormal. […] Having atypical hyperplasia increases the risk for breast cancer. This risk is even higher in women who have a family history of breast cancer or who are diagnosed with atypical hyperplasia before they reach menopause. Breast cancer is more likely to start in the breast where atypical hyperplasia is found. The risk of developing breast cancer is greatest 10-15 years after atypical hyperplasia is diagnosed. The risk begins to go down after 15 years. […] Women with atypical hyperplasia should talk to their healthcare team about the benefits and possible risks of taking SERMs to reduce their risk of breast cancer.

• #49 Breast Pre-Cancer Conditions | Atypical Hyperplasia Treatment

  https://www.drnicoleyap.com.au/breast-pre-cancer-conditions/

  It is not clear what causes atypical hyperplasia. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. […] Once diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who do not have hyperplasia. […] The breast cancer risk with women with atypical hyperplasia increases over time: At 5 years after diagnosis, about 7% of women with atypical hyperplasia may develop breast cancer. […] At 10 years after diagnosis, about 13% of women with atypical hyperplasia may develop breast cancer. […] At 25 years after diagnosis, about 30% of women with atypical hyperplasia may develop breast cancer.

• #50 Atypical hyperplasia of the breast | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/breast/what-is-breast-cancer/non-cancerous-conditions/atypical-hyperplasia

  Hyperplasia is an increase in the number of normal cells growing in a tissue. Atypical hyperplasia means that the cells that are increasing in a tissue are abnormal. […] Having atypical hyperplasia increases the risk for breast cancer. This risk is even higher in women who have a family history of breast cancer or who are diagnosed with atypical hyperplasia before they reach menopause. Breast cancer is more likely to start in the breast where atypical hyperplasia is found. The risk of developing breast cancer is greatest 10-15 years after atypical hyperplasia is diagnosed. The risk begins to go down after 15 years. […] Women with atypical hyperplasia should talk to their healthcare team about the benefits and possible risks of taking SERMs to reduce their risk of breast cancer.

• #51 Breast Pre-Cancer Conditions | Atypical Hyperplasia Treatment

  https://www.drnicoleyap.com.au/breast-pre-cancer-conditions/

  It is not clear what causes atypical hyperplasia. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. […] Once diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who do not have hyperplasia. […] The breast cancer risk with women with atypical hyperplasia increases over time: At 5 years after diagnosis, about 7% of women with atypical hyperplasia may develop breast cancer. […] At 10 years after diagnosis, about 13% of women with atypical hyperplasia may develop breast cancer. […] At 25 years after diagnosis, about 30% of women with atypical hyperplasia may develop breast cancer.

• #52 February 25, 2015 – Expect Questions About Atypical Hyperplasia as an Important Risk Factor for Breast Cancer – The ASCO Post

  https://ascopost.com/issues/february-25-2015/expect-questions-about-atypical-hyperplasia-as-an-important-risk-factor-for-breast-cancer/

  The younger a woman is when diagnosed with atypical hyperplasia, the more likely it is that breast cancer will eventually develop over the course of her lifetime. […] A special report in The New England Journal of Medicine concluded that atypical hyperplasia of the breast confers an absolute risk of later breast cancer of 30% at 25 years of follow-up. […] The data are strong enough that we can say that for any woman who has atypical hyperplasia, whether she is younger or older, a general estimate for her risk of developing breast cancer is about 1% per year. […] Women with three or more foci of atypical hyperplasia have had a risk of 47% at 25 years, or about 2% per year. […] The risk for women with atypical hyperplasia meets or exceeds that level. […] Because it is not cancer, and even though the data show that 30% of women with atypical hyperplasia developed breast cancer in 25 years, you can look at it the other way around70% of them did not.

• #53 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Atypical hyperplasia is found in approximately 10% of all benign breast biopsies. […] Once a woman is diagnosed with atypical hyperplasia, she has a cumulative incidence of breast cancer (either ductal carcinoma in situ or invasive cancer) of 30% over the next 25 years, based on the Mayo Clinic Cohort study. […] The risk of breast cancer is higher in those diagnosed with atypical hyperplasia at a younger age and in those with a greater number of foci containing atypia. […] 97% of atypical ductal hyperplasia and 88% of atypical lobular hyperplasia has estrogen receptor staining, meaning it is stimulated by estrogen. […] Because of this, medications called selective estrogen receptor modulators (for example, tamoxifen and raloxifene) and aromatase inhibitors (for example, exemestane, anastrozole, and letrozole) have been shown in clinical trials to effectively reduce the risk of breast cancer associated with these lesions.

• #54 February 25, 2015 – Expect Questions About Atypical Hyperplasia as an Important Risk Factor for Breast Cancer – The ASCO Post

  https://ascopost.com/issues/february-25-2015/expect-questions-about-atypical-hyperplasia-as-an-important-risk-factor-for-breast-cancer/

  The younger a woman is when diagnosed with atypical hyperplasia, the more likely it is that breast cancer will eventually develop over the course of her lifetime. […] A special report in The New England Journal of Medicine concluded that atypical hyperplasia of the breast confers an absolute risk of later breast cancer of 30% at 25 years of follow-up. […] The data are strong enough that we can say that for any woman who has atypical hyperplasia, whether she is younger or older, a general estimate for her risk of developing breast cancer is about 1% per year. […] Women with three or more foci of atypical hyperplasia have had a risk of 47% at 25 years, or about 2% per year. […] The risk for women with atypical hyperplasia meets or exceeds that level. […] Because it is not cancer, and even though the data show that 30% of women with atypical hyperplasia developed breast cancer in 25 years, you can look at it the other way around70% of them did not.

• #55 Proliferative Breast Disease with Atypia | Dr. Garvit

  https://drgarvitchitkara.com/blogs/managing-proliferative-breast-disease-with-atypia/

  Years of research have demonstrated that a woman’s later risk of developing breast cancer increases with her age at the time of her atypical hyperplasia diagnosis. […] Proliferative breast disease with atypia is typically diagnosed with a biopsy, a procedure where a sample of breast tissue is taken and evaluated by a pathologist, says highly-skilled surgical oncologist Dr. Garvit Chitkara. […] Proliferative breast disease with atypia treatment usually involves the surgical removal of the area where atypical cells were found through a lumpectomy or excisional biopsy and recently […] Vaccum assisted breast biopsy (VABB) has also been added to the armamentarium of breast biopsy techniques. This is done to both establish a definitive diagnosis and reduce the risk of potential progression to breast cancer. […] Women can also have proliferative breast disease without atypia, a condition that does not exhibit the abnormal cellular features seen in atypical hyperplasia, adds Dr. Garvit Chitkara.

• #56 Atypical hyperplasia of the breast – Humanitas.net

  https://www.humanitas.net/diseases/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia of the breast refers to accumulation of abnormal cells in the breast and is considered to be a precancerous condition that affects cells in the breast. It is not clear what causes atypical hyperplasia. Atypical hyperplasia forms when breast cells become abnormal in number, size, shape, growth pattern and appearance. Researchers have discovered that women with atypical hyperplasia of the breast are at higher risk for developing breast cancer. Women diagnosed with atypical hyperplasia have an increased risk of developing breast cancer in the future. It is about four times higher than that of women who do not have atypical hyperplasia. Being diagnosed with atypical hyperplasia at a younger age may increase the risk of breast cancer even more. For example, women diagnosed with atypical hyperplasia before age 45 seem to have a greater risk of developing breast cancer during their lifetimes.

• #57 February 25, 2015 – Expect Questions About Atypical Hyperplasia as an Important Risk Factor for Breast Cancer – The ASCO Post

  https://ascopost.com/issues/february-25-2015/expect-questions-about-atypical-hyperplasia-as-an-important-risk-factor-for-breast-cancer/

  The younger a woman is when diagnosed with atypical hyperplasia, the more likely it is that breast cancer will eventually develop over the course of her lifetime. […] A special report in The New England Journal of Medicine concluded that atypical hyperplasia of the breast confers an absolute risk of later breast cancer of 30% at 25 years of follow-up. […] The data are strong enough that we can say that for any woman who has atypical hyperplasia, whether she is younger or older, a general estimate for her risk of developing breast cancer is about 1% per year. […] Women with three or more foci of atypical hyperplasia have had a risk of 47% at 25 years, or about 2% per year. […] The risk for women with atypical hyperplasia meets or exceeds that level. […] Because it is not cancer, and even though the data show that 30% of women with atypical hyperplasia developed breast cancer in 25 years, you can look at it the other way around70% of them did not.

• #58 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  Atypical ductal hyperplasia (ADH) is a common diagnosis in the mammographic era and a significant clinical problem with wide variation in diagnosis and treatment. […] While ADH is considered a non-obligate precursor of invasive carcinoma, the molecular taxonomy remains unknown. […] ADH is not only a risk factor for IDC, it is also considered to be a direct but non-obligate precursor to carcinoma. […] However, Hartmann et al. pointed out that risk estimation has not been calculated as cumulative incidence by the current breast cancer risk prediction tools, and that the lifetime incidence is 25-30% according to multiple large retrospective studies. […] Strikingly, the risk associated with ADH is doubled with family history, suggesting inherited factors are associated with ADH development.

• #59 Proliferative Breast Disease with Atypia | Dr. Garvit

  https://drgarvitchitkara.com/blogs/managing-proliferative-breast-disease-with-atypia/

  Atypical hyperplasia (or atypia) describes abnormal cell modifications that frequently point to precancerous or cancerous diseases. This is because of abnormal variations in cell size, shape, and organization. It calls for more research because of how important it is in pathological analyses, explains Dr. Garvit Chitkara, a breast cancer surgeon in Mumbai. […] Both ADH and ALH are conditions regarded as a marker for an increased chance of developing breast cancer, says renowned breast oncology surgeon in Mumbai, Dr. Garvit Chitkara. […] Although atypical hyperplasia falls under the umbrella of benign breast conditions, it is considered a higher-risk category for cancer. The precise degree of the risk can vary depending on several factors, including the type of atypia, age, a family history of breast cancer, and other personal risk factors.

• #60 Atypical hyperplasia of the breast – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia is a precancerous condition that affects cells in the breast. Atypical hyperplasia describes an accumulation of abnormal cells in the milk ducts and lobules of the breast. […] Atypical hyperplasia forms when breast cells become abnormal in number, size, shape, growth pattern and appearance. The appearance of the abnormal cells determines the type of atypical hyperplasia: […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: […] If you’ve been diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have hyperplasia. […] Researchers who studied women with atypical hyperplasia found breast cancer risk increased over time: […] It’s not clear what causes atypical hyperplasia.

• #61 Atypical Hyperplasia Of Breast: Causes, Symptoms, Diagnosis & Treatment

  https://www.prepladder.com/neet-pg-study-material/radiology/atypical-hyperplasia-of-breast-causes-symptoms-diagnosis-treatment-and-complications

  Atypical hyperplasia’s etiology is unclear. Atypical hyperplasia is the result of changes in the quantity, size, shape, growth pattern, and appearance of breast cells. There are two different types of atypical hyperplasia: Atypical ductal hyperplasia: The abnormal cells in the breast ducts are called „atypical ductal hyperplasia.” […] Atypical lobular hyperplasia: it is the term used to describe abnormal cells found within the breast lobules. Atypical hyperplasia is thought to be a part of the complex process of cell transformation that accumulates and ultimately results in breast cancer. The progression of breast cancer typically results in the following: Hyperplasia: The process begins when interference with normal cell growth and development results in an excess of cells that resemble normal cells (hyperplasia).

• #62 Atypical Hyperplasia Of Breast: Causes, Symptoms, Diagnosis & Treatment

  https://www.prepladder.com/neet-pg-study-material/radiology/atypical-hyperplasia-of-breast-causes-symptoms-diagnosis-treatment-and-complications

  Atypical hyperplasia’s etiology is unclear. Atypical hyperplasia is the result of changes in the quantity, size, shape, growth pattern, and appearance of breast cells. There are two different types of atypical hyperplasia: Atypical ductal hyperplasia: The abnormal cells in the breast ducts are called „atypical ductal hyperplasia.” […] Atypical lobular hyperplasia: it is the term used to describe abnormal cells found within the breast lobules. Atypical hyperplasia is thought to be a part of the complex process of cell transformation that accumulates and ultimately results in breast cancer. The progression of breast cancer typically results in the following: Hyperplasia: The process begins when interference with normal cell growth and development results in an excess of cells that resemble normal cells (hyperplasia).

• #63 Atypical Hyperplasia Of Breast: Causes, Symptoms, Diagnosis & Treatment

  https://www.prepladder.com/neet-pg-study-material/radiology/atypical-hyperplasia-of-breast-causes-symptoms-diagnosis-treatment-and-complications

  Atypical hyperplasia: The extra cells begin to appear weird as they stack on top of one another. […] Cancer in situ (noninvasive): The abnormal cells continue to proliferate and undergo mutations, ultimately leading to in situ cancer a form of cancer in which the cancer cells remain within the milk ducts. […] Invasive cancer: The abnormal cells multiply inside the duct and eventually develop into malignant cells. Invasive cancer typically spreads to surrounding lymphatic channels, blood vessels, or tissue.

• #64 Atypical Hyperplasia Of Breast: Causes, Symptoms, Diagnosis & Treatment

  https://www.prepladder.com/neet-pg-study-material/radiology/atypical-hyperplasia-of-breast-causes-symptoms-diagnosis-treatment-and-complications

  Atypical hyperplasia: The extra cells begin to appear weird as they stack on top of one another. […] Cancer in situ (noninvasive): The abnormal cells continue to proliferate and undergo mutations, ultimately leading to in situ cancer a form of cancer in which the cancer cells remain within the milk ducts. […] Invasive cancer: The abnormal cells multiply inside the duct and eventually develop into malignant cells. Invasive cancer typically spreads to surrounding lymphatic channels, blood vessels, or tissue.

• #65 Atypical Hyperplasia Of Breast: Causes, Symptoms, Diagnosis & Treatment

  https://www.prepladder.com/neet-pg-study-material/radiology/atypical-hyperplasia-of-breast-causes-symptoms-diagnosis-treatment-and-complications

  Atypical hyperplasia: The extra cells begin to appear weird as they stack on top of one another. […] Cancer in situ (noninvasive): The abnormal cells continue to proliferate and undergo mutations, ultimately leading to in situ cancer a form of cancer in which the cancer cells remain within the milk ducts. […] Invasive cancer: The abnormal cells multiply inside the duct and eventually develop into malignant cells. Invasive cancer typically spreads to surrounding lymphatic channels, blood vessels, or tissue.

• #66 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  It is unclear if a precursor lesion exists for high-grade DCIS or invasive carcinoma; however, breast cancer relative risk is increased four times when atypical hyperplasia is identified on a breast biopsy. […] Molecular studies have identified important agents related to un-checked proliferation, including cyclin D1 overexpression, p16 inactivation, HOXA inactivation, and activation of telomerase. […] The sequence and interplay of these changes are not well understood, but further studies in their relation to each other and the development of atypical proliferative lesions and breast cancer could shed light on accurate risk stratification, prognosis, and early predictors of advanced neoplasia.

• #67 Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance

  https://www.explorationpub.com/Journals/em/Article/1001205

  Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. […] Atypical ductal hyperplasia (ADH) is one of the most common high-risk lesions of the breast and confers an increased lifetime risk of developing invasive breast cancer (IBC). […] ADH carries a risk of unsampled malignancy. […] At the time of excisional biopsy, rates of upgrade to in situ or invasive malignancy range from 15% to more than 30% of high-risk breast lesions. […] ADH is associated with a 3 to 5-fold increased relative risk for breast cancer, approximately 1% absolute risk per year for at least 25 years, and a 10-20% absolute lifetime risk of invasive carcinoma development. […] The factors found to be most likely associated with increased risk for upgrade include multiple duct involvement, suspicion for DCIS, ADH found on another high-risk lesion on CNB, and diffuse calcifications on subsequent excision biopsy.

• #68 Atypical Breast Hyperplasia – MD Searchlight

  https://mdsearchlight.com/womens-health/atypical-breast-hyperplasia/

  Atypical lobular and ductal hyperplasias are abnormal growths in the breast that are considered to be high risk. It is believed that they could either progress to advanced tumors, or be a warning sign of future breast cancer. Studies suggest that these growths can be a result of changes in the genes of normal breast tissue, that lead to uncontrolled growth. One of the main causes of these genetic changes is thought to be exposure to damaging substances related to cancer. […] One such damaging substance could be estrogen, a hormone that women are exposed to in varying amounts throughout their lives. Estrogen and its byproducts have been linked with causing damage to the DNA, leading to abnormal growth, mainly in luminal progenitor cells the cells lining the breast ducts and lobules. Over a lifetime, its believed that continuous exposure to estrogen can result in a build-up of these genetic changes, which could potentially result in atypical growths in the breast.

• #69 Case: Atypical Ductal Hyperplasia – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/atypical-ductal-hyperplasia

  Atypical ductal hyperplasia (ADH) is a non-malignant but high-risk lesion associated with progression to more advanced neoplasms including ductal carcinoma in situ (DCIS) and invasive carcinoma, and as a marker for the development of additional breast cancer. […] Estrogen exposure is the primary risk factor for the development of atypical ductal hyperplasia. Estrogen and its metabolites have associated DNA-damaging effects, which lead to abnormal growth control and unchecked proliferation within breast tissue. […] However, accumulated genomic changes throughout a patients lifetime via exposure to estrogen are likely the major player behind the development of ADH and other pre-malignant and malignant lesions. […] Additional risk factors for ADH are similar to those for invasive carcinoma, including a family history of breast cancer and BRCA1/BRCA2 mutations.

• #70 Pathology Outlines – Atypical ductal hyperplasia

  https://www.pathologyoutlines.com/topic/breastadh.html

  EZH2 (enhancer of zeste homolog 2) overexpression has an important role in oncogenesis (Arch Pathol Lab Med 2018;142:1182) […] Lifelong exposure to estrogen causes a continued accumulation of genomic changes that leads to defective growth control (Cancer Prev Res (Phila) 2014;7:211) […] Shared alterations with low grade ductal carcinoma in situ: gains 1q and loss 16q-17p (Histopathology 2010;57:171)

• #71 Atypical Ductal Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562244/

  Atypical ductal hyperplasia (ADH) is a pathology finding, usually found incidentally on biopsy of the breast. […] The etiology of atypical ductal hyperplasia is unknown; however, ADH is more prevalent in patients with a strong family history of breast cancer. […] Hoogerbrugge et al. found that nearly 50% of women undergoing prophylactic mastectomies due to high family risk of breast cancer uncovered high-risk lesions, 39% of which were ADH; this suggests that there is a hereditary component involved, which requires further study. […] Additionally, a study from 2009 demonstrated that rates of ADH have declined with the loss of favor of post-menopausal hormonal therapies, suggesting this also may have been a contributing factor.

• #72 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  It is unclear if a precursor lesion exists for high-grade DCIS or invasive carcinoma; however, breast cancer relative risk is increased four times when atypical hyperplasia is identified on a breast biopsy. […] Molecular studies have identified important agents related to un-checked proliferation, including cyclin D1 overexpression, p16 inactivation, HOXA inactivation, and activation of telomerase. […] The sequence and interplay of these changes are not well understood, but further studies in their relation to each other and the development of atypical proliferative lesions and breast cancer could shed light on accurate risk stratification, prognosis, and early predictors of advanced neoplasia.

• #73 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical lobular and ductal hyperplasias are considered high-risk, pre-cursor, or pre-malignant lesions associated with either progression to advanced neoplasms or a marker for developing metachronous or synchronous breast cancer. […] A genomic change from the damaging effects of carcinogens is one of the leading theories behind the development of atypical proliferative lesions and breast cancer. […] One of the leading players in initiating this genomic change is estrogen. […] This life-long exposure to estrogen possibly represents a continued accumulation of genomic changes and damage, which may lead to the development of atypical proliferative breast lesions. […] When ADH or ALH is identified in a breast biopsy, the risk of developing DCIS or invasive breast cancer increases by four to five times with a 2:1 predilection for the ipsilateral breast versus contralateral.

• #74 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  It is unclear if a precursor lesion exists for high-grade DCIS or invasive carcinoma; however, breast cancer relative risk is increased four times when atypical hyperplasia is identified on a breast biopsy. […] Molecular studies have identified important agents related to un-checked proliferation, including cyclin D1 overexpression, p16 inactivation, HOXA inactivation, and activation of telomerase. […] The sequence and interplay of these changes are not well understood, but further studies in their relation to each other and the development of atypical proliferative lesions and breast cancer could shed light on accurate risk stratification, prognosis, and early predictors of advanced neoplasia.

• #75 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  The occurrence of ADH in the general population varies widely from 3% of benign biopsies to 8-10%, to 23%. […] These differences may also reflect geographical or temporal differences in incidence, as ADH is associated with hormone replacement therapy (HRT), use of which varies widely over time. […] Given the high upgrade rate, it is not surprising that the majority of clinicians suggest a surgical excision after ADH diagnosis on CNB to rule out concomitant malignancy. […] Unfortunately, risk prediction following ADH diagnosis is controversial, and counseling and further screening for these women diagnosed with ADH are therefore probably not adequate. […] Thus far, despite the high risk of developing cancer associated with ADH, attempts to identify clinicopathological or molecular biomarkers to predict individual risk have been unsuccessful. […] Overall, the various limitations of all the previous studies discussed in this review need to be overcome in any future study of ADH.

Zobacz więcej